Literature DB >> 25878488

Postmarketing Research and Surveillance: Issues and Challenges.

David B Resnik.   

Abstract

Year:  2008        PMID: 25878488      PMCID: PMC4394624     

Source DB:  PubMed          Journal:  Monitor (Assoc Clin Pharmacol)        ISSN: 1088-2111


× No keyword cloud information.
  8 in total

1.  Postmarketing surveillance--lack of vigilance, lack of trust.

Authors:  Phil B Fontanarosa; Drummond Rennie; Catherine D DeAngelis
Journal:  JAMA       Date:  2004-11-22       Impact factor: 56.272

2.  Drug safety. Gaps in the safety net.

Authors:  Jennifer Couzin
Journal:  Science       Date:  2005-01-14       Impact factor: 47.728

3.  How the US drug safety system should be changed.

Authors:  Brian L Strom
Journal:  JAMA       Date:  2006-05-03       Impact factor: 56.272

4.  Reform of drug regulation--beyond an independent drug-safety board.

Authors:  Wayne A Ray; C Michael Stein
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

5.  US Senate passes FDA Revitalization Act.

Authors:  Patricia Guthrie
Journal:  CMAJ       Date:  2007-07-03       Impact factor: 8.262

6.  Challenges in using observational studies to evaluate adverse effects of treatment.

Authors:  Michael D Hughes; Paige L Williams
Journal:  N Engl J Med       Date:  2007-04-26       Impact factor: 91.245

7.  Class of antiretroviral drugs and the risk of myocardial infarction.

Authors:  Nina Friis-Møller; Peter Reiss; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa El-Sadr; Rodolphe Thiébaut; Stephane De Wit; Ole Kirk; Eric Fontas; Matthew G Law; Andrew Phillips; Jens D Lundgren
Journal:  N Engl J Med       Date:  2007-04-26       Impact factor: 91.245

8.  Beyond post-marketing research and MedWatch: Long-term studies of drug risks.

Authors:  David B Resnik
Journal:  Drug Des Devel Ther       Date:  2007-10-01       Impact factor: 4.162

  8 in total
  1 in total

1.  Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics.

Authors:  Jonas Bovijn; Kristi Krebs; Chia-Yen Chen; Ruth Boxall; Jenny C Censin; Teresa Ferreira; Sara L Pulit; Craig A Glastonbury; Samantha Laber; Iona Y Millwood; Kuang Lin; Liming Li; Zhengming Chen; Lili Milani; George Davey Smith; Robin G Walters; Reedik Mägi; Benjamin M Neale; Cecilia M Lindgren; Michael V Holmes
Journal:  Sci Transl Med       Date:  2020-06-24       Impact factor: 17.956

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.